» Articles » PMID: 14706081

Molecular and Diagnostic Clinical Virology in Real Time

Overview
Publisher Elsevier
Date 2004 Jan 7
PMID 14706081
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

During the last decade, the application of both qualitative and quantitative nucleic acid detection techniques has had a major impact on diagnostics in clinical virology. Both signal and target amplification-based systems are currently used routinely in most if not all virology laboratories. However, commercial assays are only available for a very limited number of targets, and this has resulted in the development and introduction of assays developed in-house for most viral targets. With improved and automated nucleic acid sample isolation techniques, as well as real-time detection methods, a new generation of assays for most clinically important viruses is being developed. These technological improvements also make it possible to generate results with a very short turnaround time. As an example of a more individual-patient disease-management concept, we have introduced in our clinical setting the quantitative detection of Epstein-Barr virus (EBV) in T-cell-depleted allogeneic stem cell transplant patients. This has enabled us to develop models for pre-emptive anti-B-cell immunotherapy for EBV reactivation, and for reducing not only the incidence of EBV lymphoproliferative disease (EBV-LPD), but the virus-related mortality. It is now also feasible to introduce molecular testing for those viruses that can easily be detected using classical virological methods, such as culture techniques or antigen detection. Prospective studies are needed to evaluate the clinical importance of the additional positive samples detected. It should, however, be clear that a complete exchange of technology is unlikely to occur, and that complementary methods should stay operational, making possible the discovery of new viruses. Furthermore, the ability to characterise viruses more easily by sequencing opens new possibilities for epidemiological studies. There is also an urgent need, with regard to molecular diagnostic methods, for the introduction and use of standardised materials and participation in international quality control programmes. Finally, with the introduction of a universal internal control throughout the whole procedure, the accuracy of the results generated is warranted.

Citing Articles

Revolutionizing Medical Microbiology: How Molecular and Genomic Approaches Are Changing Diagnostic Techniques.

Goyal P, Bankar N, Mishra V, Borkar S, Makade J Cureus. 2023; 15(10):e47106.

PMID: 38022057 PMC: 10646819. DOI: 10.7759/cureus.47106.


Value of pneumococcal PCR in respiratory samples for exclusion of pneumococcal pneumonia.

Van Goethem S, Van Lint P, Willems P, Van Herendael B, Hoet K JAC Antimicrob Resist. 2023; 5(6):dlad115.

PMID: 37941720 PMC: 10629468. DOI: 10.1093/jacamr/dlad115.


Molecular Epidemiology and Assemblage Typing of Giardia duodenalis in School-Age Children Situated along the Southern Shoreline of Lake Malawi, Malawi.

Archer J, Cunningham L, Juhasz A, Jones S, Doull F, LaCourse J Am J Trop Med Hyg. 2023; 109(3):626-639.

PMID: 37549892 PMC: 10484258. DOI: 10.4269/ajtmh.23-0156.


Indoor air surveillance and factors associated with respiratory pathogen detection in community settings in Belgium.

Raymenants J, Geenen C, Budts L, Thibaut J, Thijssen M, De Mulder H Nat Commun. 2023; 14(1):1332.

PMID: 36898982 PMC: 10005919. DOI: 10.1038/s41467-023-36986-z.


Diagnostic Tests for COVID-19.

Phan T, Nagaro K Adv Exp Med Biol. 2021; 1318:403-412.

PMID: 33973191 DOI: 10.1007/978-3-030-63761-3_23.


References
1.
Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A . An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang. 2001; 80(1):63-71. DOI: 10.1046/j.1423-0410.2001.00003.x. View

2.
van Esser J, van der Holt B, Meijer E, Niesters H, Trenschel R, Thijsen S . Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT. Blood. 2001; 98(4):972-8. DOI: 10.1182/blood.v98.4.972. View

3.
Schuurman R, Demeter L, Reichelderfer P, Tijnagel J, de Groot T, Boucher C . Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase. J Clin Microbiol. 1999; 37(7):2291-6. PMC: 85140. DOI: 10.1128/JCM.37.7.2291-2296.1999. View

4.
Emery V, Griffiths P . Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy. Proc Natl Acad Sci U S A. 2000; 97(14):8039-44. PMC: 16666. DOI: 10.1073/pnas.140123497. View

5.
van den Hoogen B, de Jong J, Groen J, Kuiken T, de Groot R, Fouchier R . A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001; 7(6):719-24. PMC: 7095854. DOI: 10.1038/89098. View